Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Jinxin Fertility Group stock

1951.HK
KYG5140J1013
A2PL6U

Price

2.95
Today +/-
-0.00
Today %
-0.69 %
P

Jinxin Fertility Group stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Jinxin Fertility Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Jinxin Fertility Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Jinxin Fertility Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Jinxin Fertility Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Jinxin Fertility Group Stock Price History

DateJinxin Fertility Group Price
11/13/20242.95 undefined
11/13/20242.97 undefined
11/12/20243.06 undefined
11/11/20243.15 undefined
11/8/20243.22 undefined
11/7/20243.30 undefined
11/6/20243.15 undefined
11/5/20243.23 undefined
11/4/20243.13 undefined
11/1/20243.10 undefined
10/31/20243.16 undefined
10/30/20243.17 undefined
10/29/20243.22 undefined
10/28/20243.54 undefined
10/25/20243.35 undefined
10/24/20243.24 undefined
10/23/20243.35 undefined
10/22/20243.35 undefined
10/21/20243.07 undefined
10/18/20243.04 undefined
10/17/20242.83 undefined
10/16/20242.82 undefined

Jinxin Fertility Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Jinxin Fertility Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Jinxin Fertility Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Jinxin Fertility Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Jinxin Fertility Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Jinxin Fertility Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Jinxin Fertility Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Jinxin Fertility Group’s growth potential.

Jinxin Fertility Group Revenue, EBIT and net profit per share

DateJinxin Fertility Group RevenueJinxin Fertility Group EBITJinxin Fertility Group Net Income
2029e7.25 B undefined0 undefined0 undefined
2028e6.51 B undefined1.59 B undefined0 undefined
2027e5.77 B undefined1.39 B undefined0 undefined
2026e3.96 B undefined754.26 M undefined591.94 M undefined
2025e3.55 B undefined661.98 M undefined508.77 M undefined
2024e3.15 B undefined567.65 M undefined445.22 M undefined
20232.79 B undefined508.16 M undefined344.72 M undefined
20222.36 B undefined262.52 M undefined121.12 M undefined
20211.84 B undefined400.76 M undefined339.9 M undefined
20201.43 B undefined237.53 M undefined251.62 M undefined
20191.65 B undefined544.88 M undefined409.62 M undefined
2018921.99 M undefined305.7 M undefined166.6 M undefined
2017662.77 M undefined241.53 M undefined98.78 M undefined
2016346.41 M undefined106.45 M undefined87.58 M undefined

Jinxin Fertility Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (B)DOCUMENTS
201620172018201920202021202220232024e2025e2026e2027e2028e2029e
0.350.660.921.651.431.842.362.793.153.553.965.776.517.25
-91.3339.1278.94-13.4728.8928.6217.9412.8012.7211.7345.6712.7711.34
38.1545.6244.8449.5139.6241.9536.9742.1437.3633.1529.6620.3618.0616.22
0.130.30.410.820.570.770.871.18000000
8798166409251339121344445508591000
-12.6469.39146.39-38.6335.06-64.31184.3029.3614.1616.34---
--------------
--------------
0.070.581.132.212.422.52.622.74000000
--------------
Details

Keystats

ⓘ

Revenue and Growth

The Jinxin Fertility Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Jinxin Fertility Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20162017201820192020202120222023
               
0.190.451.250.630.741.931.40.85
2.966.7276.9246.0668.7564.3383.3273.09
0071.8357.8388.57452.86286.47273.12
12.7518.6916.5526.0825.4846.8162.5562.43
000.022.661.720.050.070.08
0.210.531.443.432.652.541.91.34
0.050.120.141.031.281.493.13.12
009.9910.02180.44353.17131271.58
0125.35438.17061.91209.5139.256.8
00.663.633.663.885.216.26.21
00.20.80.810.892.723.483.5
500.97100.46102.0812.34219.62300.05373.39394.79
0.551.25.125.526.5110.2813.3313.55
0.761.746.568.949.1612.8315.2314.9
               
60.2688.270.130.160.160.170.170.18
004.316.996.87.897.888.9
0.020.240.050.470.781.110.891.26
00067.26-301.96-454.37-129.47-74.93
00000-3.8900
0.080.934.367.537.288.558.6410.09
0.030.050.140.110.120.150.221.04
18.2765.84151.51124.86117.75157.81199.41164.47
0.610.081.080.170.260.670.440.32
00000000
0000.030.050.11.910.98
0.650.21.380.440.561.072.762.49
0000.150.351.992.551.81
00.170.680.710.791.011.191.21
004.7700000
00.170.680.861.1533.733.02
0.650.382.061.31.74.076.55.51
0.731.36.428.838.9812.6215.1415.61
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Jinxin Fertility Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Jinxin Fertility Group's financial health and stability.

Assets

Jinxin Fertility Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Jinxin Fertility Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Jinxin Fertility Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Jinxin Fertility Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2016201720182019202020212022
109241276547349457154
143542112130169261
0000000
-11-22946-199-158-292-11
-20-9-8-128137
17009132087
021351255147122
10847356452308343541
-8-32-20-60-323-79-959
-608-252-388-2,705-130-1,566-1,377
-600-219-367-2,645192-1,486-418
0000000
0.0300-0.030.14-0.031.32
001.133.08-0.061.010.08
0.660.460.771.65-0.060.960.46
635463-22-1,07518-26-781
00-342-327-1490-158
163258735-604101-275-359
100.9715.48335.46392.1-15.33263.62-417.65
0000000

Jinxin Fertility Group stock margins

The Jinxin Fertility Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Jinxin Fertility Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Jinxin Fertility Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Jinxin Fertility Group's sales revenue. A higher gross margin percentage indicates that the Jinxin Fertility Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Jinxin Fertility Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Jinxin Fertility Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Jinxin Fertility Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Jinxin Fertility Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Jinxin Fertility Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Jinxin Fertility Group Margin History

Jinxin Fertility Group Gross marginJinxin Fertility Group Profit marginJinxin Fertility Group EBIT marginJinxin Fertility Group Profit margin
2029e42.15 %0 %0 %
2028e42.15 %24.47 %0 %
2027e42.15 %24.04 %0 %
2026e42.15 %19.04 %14.94 %
2025e42.15 %18.67 %14.35 %
2024e42.15 %18.05 %14.16 %
202342.15 %18.22 %12.36 %
202236.98 %11.1 %5.12 %
202141.96 %21.79 %18.48 %
202039.67 %16.66 %17.64 %
201949.55 %33.05 %24.85 %
201844.81 %33.16 %18.07 %
201745.59 %36.44 %14.9 %
201638.31 %30.73 %25.28 %

Jinxin Fertility Group Stock Sales Revenue, EBIT, Earnings per Share

The Jinxin Fertility Group earnings per share therefore indicates how much revenue Jinxin Fertility Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Jinxin Fertility Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Jinxin Fertility Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Jinxin Fertility Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Jinxin Fertility Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Jinxin Fertility Group Revenue, EBIT and net profit per share

DateJinxin Fertility Group Sales per ShareJinxin Fertility Group EBIT per shareJinxin Fertility Group Earnings per Share
2029e2.63 undefined0 undefined0 undefined
2028e2.36 undefined0 undefined0 undefined
2027e2.1 undefined0 undefined0 undefined
2026e1.44 undefined0 undefined0.22 undefined
2025e1.29 undefined0 undefined0.18 undefined
2024e1.14 undefined0 undefined0.16 undefined
20231.02 undefined0.19 undefined0.13 undefined
20220.9 undefined0.1 undefined0.05 undefined
20210.73 undefined0.16 undefined0.14 undefined
20200.59 undefined0.1 undefined0.1 undefined
20190.75 undefined0.25 undefined0.19 undefined
20180.82 undefined0.27 undefined0.15 undefined
20171.15 undefined0.42 undefined0.17 undefined
20165.11 undefined1.57 undefined1.29 undefined

Jinxin Fertility Group business model

The company Jinxin Fertility Group Ltd is a company that was founded in China and specializes in reproductive medicine. The company's history began in 2003 when a team of experts and doctors decided to establish a center for assisted reproduction. Since then, the company has grown to become one of the largest centers for assisted reproduction in China, with more than 30 branches in different regions of China. The business model of Jinxin Fertility Group Ltd is focused on helping couples who have difficulties conceiving. The company offers a wide range of reproductive medicine and fertility services to help couples successfully achieve a pregnancy and have a healthy baby. Jinxin Fertility Group Ltd is a leading provider of assisted reproduction in China and offers a wide range of services, including in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), egg donation, sperm donation, and artificial insemination. The company works with the latest medical devices and technologies to achieve the best results for its patients. Jinxin Fertility Group Ltd also operates its own research laboratory, where the latest advancements in fertility treatment and reproductive medicine are studied. The company also collaborates closely with leading experts and researchers in the field to ensure that its patients have access to the latest developments and technologies. The different divisions of the company include reproductive medicine, obstetrics and gynecology, as well as counseling and support for patients and families before, during, and after pregnancy. The company also offers its services in specialized fertility and women's health clinics that specialize in the treatment of infertility and other fertility problems. Jinxin Fertility Group Ltd also offers specialized services for couples with special medical needs due to genetic disorders or hereditary diseases. These services include genetic counseling, prenatal diagnostics, and genetic screening tests. In terms of the products offered by Jinxin Fertility Group Ltd, the company works closely with leading manufacturers of medical devices and consumables to ensure that it can provide its patients with the best products available. The company supplies its clinics and branches with high-quality medical devices and materials to ensure that its patients receive the best possible care. In summary, Jinxin Fertility Group Ltd is a leading provider of assisted reproduction in China that specializes in providing high-quality reproductive medicine and fertility services. The company collaborates closely with leading experts and researchers in the field to ensure that it offers its patients access to the latest developments and technologies. With a wide range of services and a deep commitment to excellence and patient care, Jinxin Fertility Group Ltd is a key player in the Chinese market for assisted reproduction. Jinxin Fertility Group is one of the most popular companies on Eulerpool.com.

Jinxin Fertility Group SWOT Analysis

Strengths

Jinxin Fertility Group Ltd has several key strengths that contribute to its competitive advantage:

  • Strong brand reputation and recognition in the fertility industry.
  • Experienced and highly skilled team of fertility specialists and staff.
  • State-of-the-art facilities and advanced medical equipment.
  • Wide range of fertility treatment options, catering to diverse patient needs.
  • Established network and partnerships with healthcare providers, ensuring a steady flow of patients.

Weaknesses

Despite its strengths, Jinxin Fertility Group Ltd faces certain weaknesses that may pose challenges:

  • Relatively high treatment costs, making it less accessible for lower-income individuals.
  • Limited geographical presence, primarily concentrated in a few key regions.
  • Potential dependency on specific fertility treatments, reducing flexibility in meeting evolving patient demands.
  • Intense competition from other established fertility clinics and hospitals.
  • Limited public awareness and education about fertility issues, hindering market growth.

Opportunities

Jinxin Fertility Group Ltd can capitalize on the following opportunities to further expand and strengthen its position:

  • Increasing societal acceptance and demand for fertility treatments, driven by changing lifestyle factors.
  • Exploring untapped markets by expanding into new geographical regions.
  • Investing in research and development to enhance existing treatments and develop innovative solutions.
  • Strategic partnerships with pharmaceutical companies to offer comprehensive fertility solutions.
  • Providing specialized fertility services for international patients and medical tourism.

Threats

Jinxin Fertility Group Ltd should be aware of the following threats that could impact its business:

  • Stringent government regulations and changing healthcare policies affecting fertility treatments.
  • Economic downturns and financial uncertainties potentially reducing patient willingness to invest in fertility treatments.
  • Emergence of new competitors with disruptive technologies and alternative treatment approaches.
  • Risks associated with medical malpractice and potential legal liabilities.
  • Negative publicity or controversies related to fertility treatments impacting the company's reputation.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Jinxin Fertility Group Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Jinxin Fertility Group historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Jinxin Fertility Group shares outstanding

The number of shares was Jinxin Fertility Group in 2023 — This indicates how many shares 2.736 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Jinxin Fertility Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Jinxin Fertility Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Jinxin Fertility Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Jinxin Fertility Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Jinxin Fertility Group dividend history and estimates

In 2023, Jinxin Fertility Group paid a dividend amounting to 0 CNY. Dividend means that Jinxin Fertility Group distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Jinxin Fertility Group provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Jinxin Fertility Group’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Jinxin Fertility Group's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Jinxin Fertility Group Dividend History

DateJinxin Fertility Group Dividend
2026e0.26 undefined
2025e0.24 undefined
2024e0.2 undefined
20220.07 undefined
20200.07 undefined

Jinxin Fertility Group dividend payout ratio

In 2023, Jinxin Fertility Group had a payout ratio of 109.42%. The payout ratio indicates the percentage of the company's profits that Jinxin Fertility Group distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Jinxin Fertility Group represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Jinxin Fertility Group could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Jinxin Fertility Group's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Jinxin Fertility Group Payout Ratio History

DateJinxin Fertility Group Payout ratio
2029e123.47 %
2028e124.86 %
2027e124.68 %
2026e120.86 %
2025e129.04 %
2024e124.13 %
2023109.42 %
2022153.56 %
2021109.42 %
202065.28 %
2019109.42 %
2018109.42 %
2017109.42 %
2016109.42 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Jinxin Fertility Group.

Eulerpool ESG Scorecard© for the Jinxin Fertility Group stock

Eulerpool World ESG Rating (EESG©)

72/ 100

🌱 Environment

84

👫 Social

99

🏛️ Governance

33

Environment

Scope 1 - Direct Emissions
1,457.98
Scope 2 - Indirect emissions from purchased energy
12,118.4
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
13,576.4
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees85.466
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Jinxin Fertility Group shareholders

%
Name
Stocks
Change
Date
11.60438 % JINXIN Fertility Investment Group Ltd.319,471,061012/31/2023
10.48230 % HRC Investment Holding, LLC288,580,005012/31/2023
6.39956 % HHLR Advisors, Ltd.176,181,349012/31/2023
2.67351 % The Vanguard Group, Inc.73,602,1762,156,5009/30/2024
2.16651 % HuaAn Fund Management Co., Ltd.59,644,50059,644,5006/30/2024
1.36020 % Bosera Asset Management Co., Ltd.37,446,5002,536,5006/30/2024
0.92428 % Dimensional Fund Advisors, L.P.25,445,50009/30/2024
0.80742 % BlackRock Institutional Trust Company, N.A.22,228,50077,0009/30/2024
0.55046 % Huashang Fund Management Co., Ltd.15,154,3772,626,3776/30/2024
0.42795 % China Asset Management Co., Ltd.11,781,5001,877,0006/30/2024
1
2
3
4
5
...
10

Jinxin Fertility Group Executives and Management Board

Mr. Yong Zhong(51)
Jinxin Fertility Group Executive Chairman of the Board (since 2018)
Compensation 3.74 M
Ms. Rong Lyu(42)
Jinxin Fertility Group Co-Chief Executive Officer, Executive Director (since 2021)
Compensation 3.31 M
Mr. Yang Dong(36)
Jinxin Fertility Group Co-Chief Executive Officer, Executive Director (since 2018)
Compensation 2.69 M
Dr. Lihong Geng(54)
Jinxin Fertility Group Executive Director (since 2021)
Compensation 1.51 M
Ms. Xiaoqing Yan(53)
Jinxin Fertility Group Senior Vice President, Non-Executive Director (since 2018)
Compensation 616,000
1
2
3
4

Most common questions regarding Jinxin Fertility Group

What values and corporate philosophy does Jinxin Fertility Group represent?

Jinxin Fertility Group Ltd is dedicated to providing reliable and innovative reproductive healthcare solutions. With a strong commitment to ethical practices, they prioritize patient safety and satisfaction. Jinxin Fertility Group Ltd's corporate philosophy revolves around promoting and advancing fertility treatments, ensuring accessibility and affordability for couples seeking infertility care. By combining cutting-edge technology with personalized care, they aim to achieve high success rates in assisted reproductive technology procedures. Jinxin Fertility Group Ltd values integrity, professionalism, and excellence in delivering comprehensive fertility services, fostering hope, and making dreams of starting a family come true.

In which countries and regions is Jinxin Fertility Group primarily present?

Jinxin Fertility Group Ltd is primarily present in China.

What significant milestones has the company Jinxin Fertility Group achieved?

Jinxin Fertility Group Ltd has achieved several significant milestones. Firstly, the company successfully listed on the Stock Exchange of Hong Kong in 2018, marking a major achievement in its growth trajectory. Additionally, Jinxin Fertility Group Ltd has expanded its presence by opening multiple fertility treatment centers across China, solidifying its position as a leading provider of reproductive health services in the country. The company has also achieved noteworthy advancements in technology and research, consistently introducing innovative techniques and treatments to enhance patient outcomes. With its commitment to excellence and continuous development, Jinxin Fertility Group Ltd has established itself as a prominent player in the fertility industry.

What is the history and background of the company Jinxin Fertility Group?

Jinxin Fertility Group Ltd is a leading company in the fertility industry. Established in XXXX, it has quickly gained prominence for its innovative fertility treatments and advanced technology. With a wide range of services including in-vitro fertilization (IVF), preimplantation genetic diagnosis (PGD), and reproductive surgery, Jinxin Fertility Group Ltd has successfully helped countless individuals and couples achieve their dream of parenthood. The company is known for its state-of-the-art facilities and highly skilled medical professionals who are dedicated to providing personalized care and support throughout the journey to conception. As a trusted name in the field, Jinxin Fertility Group Ltd continues to revolutionize the fertility industry and bring hope to those struggling with infertility.

Who are the main competitors of Jinxin Fertility Group in the market?

The main competitors of Jinxin Fertility Group Ltd in the market include other prominent players in the fertility services industry, such as Hangzhou Tigermed Consulting Co., Ltd, New Hope Fertility Co., Ltd, and Merck KGaA. These competitors possess similar expertise in the field of assisted reproductive technology and offer comparable services to individuals and couples seeking fertility treatments. By constantly innovating and delivering high-quality fertility solutions, Jinxin Fertility Group Ltd strives to maintain a competitive edge in the market against these key rivals.

In which industries is Jinxin Fertility Group primarily active?

Jinxin Fertility Group Ltd is primarily active in the healthcare and fertility industry.

What is the business model of Jinxin Fertility Group?

The business model of Jinxin Fertility Group Ltd revolves around providing comprehensive fertility services and solutions. Jinxin Fertility Group Ltd specializes in offering a wide range of assisted reproductive technology (ART) services, including in vitro fertilization (IVF), genetic testing, and fertility preservation. The company's goal is to assist individuals and couples in overcoming fertility challenges and achieving their dream of starting a family. Jinxin Fertility Group Ltd is committed to delivering high-quality, personalized care to its patients, supported by a team of experienced fertility specialists and state-of-the-art facilities. Its business model combines medical expertise, advanced technology, and compassionate care to meet the diverse needs of its clients.

What is the P/E ratio of Jinxin Fertility Group 2024?

The Jinxin Fertility Group P/E ratio is 18.15.

What is the P/S ratio of Jinxin Fertility Group 2024?

The Jinxin Fertility Group P/S ratio is 2.57.

What is the Quality Investing of Jinxin Fertility Group?

The Quality Investing for Jinxin Fertility Group is 3/10.

What is the revenue of Jinxin Fertility Group 2024?

The expected Jinxin Fertility Group revenue is 3.15 B CNY.

How high is the profit of Jinxin Fertility Group 2024?

The expected Jinxin Fertility Group profit is 445.22 M CNY.

What is the business model of Jinxin Fertility Group

Jinxin Fertility Group Ltd is an internationally recognized clinic group specializing in reproductive medicine. With comprehensive medical expertise, the latest treatment technologies, and a respectful approach to patients' individual needs, Jinxin Fertility has become a leading service provider in this field. An important part of Jinxin Fertility Group's business model is to offer high-quality services and products that meet the needs of patients in different income groups. This includes a wide range of treatments and procedures, from basic consultations to complex invasive techniques such as in-vitro fertilization (IVF). In addition to fertility treatment, Jinxin Fertility Group also offers other services, including preventive healthcare, cosmetic gynecology, and medical tourism. Patients from around the world come to avail themselves of the services of Jinxin Fertility Group. There has been an increase in the number of patients, particularly from Asian countries such as Japan, Korea, Vietnam, and Thailand. But European and American patients are also increasingly choosing the group's services. The group has a very large network of internationally recognized specialists in the field of reproductive medicine. The doctors and medical staff are highly qualified and have extensive experience. They work with state-of-the-art technology and utilize the latest innovations in fertility treatment. Jinxin Fertility Group also offers special programs for couples experiencing difficulty in achieving pregnancy, such as the "Baby Now" program. This is a customized package of IVF treatment. The program includes comprehensive pre-examinations, individual treatment with cutting-edge technologies and medications, as well as continuous monitoring and a special care program. Another important component of Jinxin Fertility Group's business model is to continue developing new methods and treatments through medical progress and research to increase the chances of successful pregnancy. The group collaborates with leading research institutes and specialized institutions around the world. Overall, Jinxin Fertility Group is an established and successful clinic group with a comprehensive range of services and products in the field of reproductive medicine. The group is focused on a broad national and international customer portfolio and offers a comprehensive program of research, diagnostics, and treatment. Its goal is always to maximize the chances of pregnancy for each individual patient.

What is the Jinxin Fertility Group dividend?

Jinxin Fertility Group pays a dividend of 0.07 CNY distributed over payouts per year.

How often does Jinxin Fertility Group pay dividends?

The dividend cannot currently be calculated for Jinxin Fertility Group or the company does not pay out a dividend.

What is the Jinxin Fertility Group ISIN?

The ISIN of Jinxin Fertility Group is KYG5140J1013.

What is the Jinxin Fertility Group WKN?

The WKN of Jinxin Fertility Group is A2PL6U.

What is the Jinxin Fertility Group ticker?

The ticker of Jinxin Fertility Group is 1951.HK.

How much dividend does Jinxin Fertility Group pay?

Over the past 12 months, Jinxin Fertility Group paid a dividend of 0.07 CNY . This corresponds to a dividend yield of about 2.5 %. For the coming 12 months, Jinxin Fertility Group is expected to pay a dividend of 0.24 CNY.

What is the dividend yield of Jinxin Fertility Group?

The current dividend yield of Jinxin Fertility Group is 2.5 %.

When does Jinxin Fertility Group pay dividends?

Jinxin Fertility Group pays a quarterly dividend. This is distributed in the months of August, July, July, August.

How secure is the dividend of Jinxin Fertility Group?

Jinxin Fertility Group paid dividends every year for the past 0 years.

What is the dividend of Jinxin Fertility Group?

For the upcoming 12 months, dividends amounting to 0.24 CNY are expected. This corresponds to a dividend yield of 8.02 %.

In which sector is Jinxin Fertility Group located?

Jinxin Fertility Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jinxin Fertility Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jinxin Fertility Group from 7/25/2024 amounting to 0.01 CNY, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Jinxin Fertility Group pay the last dividend?

The last dividend was paid out on 7/25/2024.

What was the dividend of Jinxin Fertility Group in the year 2023?

In the year 2023, Jinxin Fertility Group distributed 0.074 CNY as dividends.

In which currency does Jinxin Fertility Group pay out the dividend?

The dividends of Jinxin Fertility Group are distributed in CNY.

All fundamentals about Jinxin Fertility Group

Our stock analysis for Jinxin Fertility Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jinxin Fertility Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.